Freeline Therapeutics Holdings plc (FRLN)

the markets judgement about their pipeline is pretty clear :-((

can;t wait for the wake-up call, too many analysts have price targets way above this ($2, $6, $10...) worst case is a double, average case is a 5 bagger

Short interest, no patients in clinical trials, no new data, way overvalued

#BullishCharts: The Road To $1M+ Complete / Celebratory NYC Re-opening @ Time Square & Nusr-Et Steakhouse! #Saltbae

#YouTube | Link >> https://youtu.be/zCvBGLhxh9c

Syncona now has 63% stake in company. 13-D filed.

Is there any value in their pipeline ?

This is way undervalued

It’s positioned to $2 range in few days.

Volume is picking up significantly. Pre-market volume is now as high as daily volumes earlier this month. They have received additional funding recently and are now accelerating their plans for Fabry. I feel a biotech wave (which could turn into a tsunami) coming to Wall Street soon. Extremely undervalued sector...

Could it reach $2.00 Today ..?

Looks like someone bought 65% of the company last week!

12K share buy just crossed the tape, someone in England must know something, GL Monday guys

Anyone shorting this last Friday AH ?

Freeline Therapeutics is down 10.10% to 0.81

Interesting that they are raising another $25M when they already have $135M in the bank. Looks like Syncona Limited, a multi-billion dollar, UK based Healthcare hedge fund, is going all in with a 50% stake in Freeline at $1.05/share. They had a 10% stake before. I believe this is good news?

Freeline Therapeutics is up 7.75% to 0.90

Freeline Therapeutics is up 11.69% to 0.84

Freeline Therapeutics is down 9.28% to 0.77

Freeline Therapeutics reached a 52 Week low at 0.89

Freeline Therapeutics is down 9.51% to 0.92